Pharmagene Discovery Services

Executive Summary

Pharmagene Discovery Services is a UK-based contract research organization (CRO) specializing in drug discovery support. Founded in 1996 and headquartered in Cambridge, the company integrates high-quality human biospecimens, advanced translational models, and deep scientific expertise to provide tailored, insight-driven data that de-risks drug development. Its services aim to accelerate preclinical programs, ultimately advancing human health. As a private, pre-clinical stage company, Pharmagene has established a reputation for reliable and high-fidelity data delivery, serving pharmaceutical and biotech clients seeking to optimize their drug discovery pipelines. The company operates in the small molecules and drug discovery categories, leveraging its long-standing industry presence to build trust and repeat business. With a strong focus on translational relevance, Pharmagene addresses a critical need in the industry: improving the predictive value of preclinical studies. The company's sustained operations since 1996 underscore its resilience and adaptability in a competitive CRO landscape. However, its private status limits public visibility into financial performance or pipeline progress.

Upcoming Catalysts (preview)

• Q3 2026Launch of New Humanized Model Platform70% success
• Q4 2026Strategic Partnership with Major Pharma60% success
• TBDFDA Endorsement of Translational Model50% success